Free Trial

Biofrontera (BFRIW) Competitors

$0.05 0.00 (0.00%)
(As of 11/20/2024 ET)

BFRIW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ALVO, ACABW, ACABU, BTMDW, and BCTXW

Should you be buying Biofrontera stock or one of its competitors? The main competitors of Biofrontera include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Alvotech (ALVO), Atlantic Coastal Acquisition Corp. II (ACABW), Atlantic Coastal Acquisition Corp. II (ACABU), biote (BTMDW), and BriaCell Therapeutics (BCTXW). These companies are all part of the "pharmaceutical products" industry.

Biofrontera vs.

Biofrontera (NASDAQ:BFRIW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, profitability, dividends, valuation, earnings, community ranking, risk and analyst recommendations.

In the previous week, Biofrontera's average media sentiment score of 0.00 equaled 180 Life Sciences'average media sentiment score.

Company Overall Sentiment
Biofrontera Neutral
180 Life Sciences Neutral

Biofrontera and 180 Life Sciences both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
BiofronteraN/AN/A
180 Life SciencesN/AN/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Biofrontera$35.24MN/AN/AN/AN/A
180 Life SciencesN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
BiofronteraN/A N/A N/A
180 Life Sciences N/A N/A N/A

Summary

Biofrontera beats 180 Life Sciences on 1 of the 1 factors compared between the two stocks.

Get Biofrontera News Delivered to You Automatically

Sign up to receive the latest news and ratings for BFRIW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BFRIW vs. The Competition

MetricBiofronteraDrug Manufacturers IndustryMedical SectorNASDAQ Exchange
Market CapN/A$1.17B$5.07B$8.90B
Dividend YieldN/A3.13%4.99%4.07%
P/E RatioN/A109.9787.8613.46
Price / SalesN/A1,928.501,228.8287.66
Price / CashN/A10.4339.5136.27
Price / BookN/A3.116.946.30
Net IncomeN/A$159.31M$119.12M$225.93M
7 Day PerformanceN/A-1.23%-1.84%-1.32%
1 Month PerformanceN/A-3.92%-3.65%0.60%
1 Year PerformanceN/A87.59%31.64%26.23%

Biofrontera Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BFRIW
Biofrontera
N/A$0.05
flat
N/A+179.9%$0.00$35.24M0.0070
ATNFW
180 Life Sciences
N/A$0.01
flat
N/A-25.0%$0.00N/A0.007
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522,000.000.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.04
-20.6%
N/A-71.9%$0.00N/A0.002
AIMDW
Ainos
N/A$0.03
flat
N/AN/A$0.00$40,633.000.0040
ALVOW
Alvotech
N/A$3.10
-7.7%
N/A+105.3%$0.00$306.77M0.004
ALVO
Alvotech
2.2902 of 5 stars
$12.42
-0.6%
$18.00
+44.9%
+35.9%$0.00$93.38M-6.711,026
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.08
flat
N/A+77.4%$0.00N/A0.004
ACABU
Atlantic Coastal Acquisition Corp. II
N/A$8.05
-26.8%
N/A-23.6%$0.00N/A0.004Gap Down
BTMDW
biote
N/A$0.50
flat
N/AN/A$0.00$187.23M0.00N/A
BCTXW
BriaCell Therapeutics
N/A$0.35
+25.0%
N/A-80.6%$0.00N/A0.008Gap Down

Related Companies and Tools


This page (NASDAQ:BFRIW) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners